Prf Technologies Ltd Revenue per Employee (PRFX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Prf Technologies Ltd   (NASDAQ: PRFX)
 

Prf Technologies Ltd 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Prf Technologies Ltd 's Revenue per employee grew on a trailing twelve month basis to , the productivity of Prf Technologies Ltd 's employees reached a new high of $ 2,429.
Within the Healthcare sector Employees of 577 other companies have achieved higher revenue per employee. While Prf Technologies Ltd 's total ranking has deteriorated compared to the previous quarter from 0 to 3957. Prf Technologies Ltd has 7 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRFX Revenue per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Revenue Change - - - - -
Sales per Employee (TTM) $ 2,429 - - - -
PRFX's Total Ranking # 3957 # 0 # # #
Seq. Revenue Change - - - - -

PRFX Company Profile >> Back to PRFX Efficiency Comparisons >> Compare PRFX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 218
Healthcare Sector # 578
Overall Market # 3957

Revenue per Employee Statistics
High Average Low
$ 2,429 $ 2,429 $ 2,429
(Dec 31 2025)  



Financial Statements
Prf Technologies Ltd 's Revenue MRQ $ 0 Millions Visit PRFX's Income Statement
Prf Technologies Ltd 's Revenues TTM $ 0 Millions Visit PRFX's aggregate revenue growth
What are PRFX's Sales? Visit PRFX's Sales by Segment




Other Ratios
Prf Technologies Ltd 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PRFX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PRFX's Competitors
Revenue per Employee for PRFX's Suppliers
Revenue per Employee for PRFX's Customers

You may also want to know
PRFX's Sales Growth Rates PRFX's Pe Price to earnings ratio PRFX's Receivables Turnover Ratio PRFX's Stock Quote
PRFX's Net Income Growth Rates PRFX's Ps Price to Sales ratio PRFX's Sales per Employee PRFX's Asset Turnover Ratio
PRFX's Net Margin PRFX's Pb Price to Book ratio PRFX's Financial Strength Ratios PRFX's Dividend Payout Ratio
Date modified: 2026-07-07T12:39:15+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Aim Immunotech Inc   4,190.48 $ 0.088  Million 21 
Prokidney Corp   3,865.80 $ 0.893  Million 231 
Ainos Inc   3,028.22 $ 0.124  Million 41 
Clene Inc   2,531.65 $ 0.200  Million 79 
Prf Technologies Ltd   2,428.57 $ 0.017  Million 7 
Addex Therapeutics Ltd  1,763.06 $ 0.030  Million 17 
Pavmed Inc   1,731.71 $ 0.071  Million 41 
Hcw Biologics Inc   1,546.14 $ 0.054  Million 35 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.